Clinical trial
A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
NCT06564818 is registered in ClinicalTrials.gov with Cybin IRL Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
- Lead sponsor
- Cybin IRL Limited
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- December 17, 2024
- Completion date
- October 31, 2026
- Enrollment
- 220 (estimated)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.